Why the study?
Kimura's disease is difficult to diagnose, and few studies have reported on the characteristics and usefulness of 18F-FDG PET/CT in these patients.
18F-FDG PET/CT in Kimura's disease typically shows homogeneous lesions with high uptake (SUVmax > 2.5) in regional or generalized lymphadenopathy, which negatively correlates with eosinophil levels.
May aid KD evaluation on 18F-FDG PET/CT; leaves open prospective validation before clinical adoption.
‘ Kimura’s disease (KD) is a rare chronic inflammatory disorder of unknown etiology and is difficult to diagnose due to poor clinical presentation and imaging features. Few studies on characteristics of 18 F-FDG PET/CT of KD have been reported. This study aimed to observe the reliable characteristics and usefulness of 18 F-FDG PET/CT for the evaluation of consecutive patients with KD. The clinical data and 18 F-FDG PET/CT imaging findings of 8 patients with pathologically confirmed KD were reviewed retrospectively. 18 F-FDG PET/CT images were evaluated visually and semiquantitatively by measuring the maximum standardized uptake value (SUV max ). The correlations between clinical data and 18 F-FDG PET/CT features were analyzed by simple linear regression. This study included 7 males and one female ranging in age from 17 to 79 years. The longest diameter of lesions ranged from 0.8 cm to 4.8 cm, and regional or generalized lymphadenopathy was found in all 8 patients with eosinophilia, while subcutaneous masses and salivary gland involvement concurrently were found in 4 patients. 18 F-FDG PET/CT revealed that these involved lesions had high 18 F-FDG uptake with SUV max > 2.5 (2.6 to 6.3). Moreover, the margin of the lesions was well defined in 6 cases and ill defined in 2 cases, and homogeneous density and 18 F-FDG uptake were both found in all these lesions. There was negative correlation between eosinophils and SUV max ( R 2 = 0.538). Kimura’s disease should be considered when 18 F-FDG PET/CT is characterized by homogeneous lesions of regional or generalized lymphadenopathy, accompanied with subcutaneous masses and salivary gland involvement concurrently, especially in patients with eosinophilia.
No takes yet. Share an insight, caveat, or question.
Xu et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: